NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
October 7, 2008 • Volume 5 / Number 20 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Initiative to Speed Clinical Trial Negotiations Moves Forward

Cancer Research Highlights
Several Colorectal Cancer Screening Methods Are Equally Effective, Panel Says

Shorter Course of Radiation Effective for Some Women with Breast Cancer

Kidney Cancer Drug Benefits Older Patients, Too

No Survival Benefit from Adjuvant Chemo in Stage 1B NSCLC

Director's Update
Becoming a Model for Tackling the Cancer Burden

Funding Opportunities

Legislative Update
Hoover Testifies on Cell Phone Use and Brain Tumors

FDA Update
Erlotinib Safety Warning for Patients Who Have Liver Disease

Spotlight
What Comes After PSA?

A Closer Look
Closing In on Cancers of Unknown Primary Origin

Featured Clinical Trial
Using Circulating Tumor Cells to Guide Treatment

Notes
Cervical Cancer, AIDS Discoveries Share Nobel Prize

LoRusso Receives Michaele C. Christian Lectureship

Zerhouni Will Step Down as NIH Director

NCI Proteomics Meeting to Focus on Laboratory Variability

Cancer.gov Update
NCI Introduces Updated SEER Web Site

Cancer Center Profile
University of Virginia Cancer Center

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Special Report Special Report

Hoover Testifies on Cell Phone Use and Brain Tumors

On September 25, the Subcommittee on Domestic Policy of the U.S. House of Representatives' Committee on Oversight and Government Reform held a hearing titled "Cell Phone Use and Tumors: What the Science Says." Subcommittee Chairman Dennis Kucinich (D-OH) asked the panel whether there is sufficient evidence [of long-term cell phone exposure causing brain tumors] "to merit action by regulators and legislators to protect the public health." Dr. Robert Hoover, director of the Epidemiology and Biostatistics Program in NCI's Division of Cancer Epidemiology and Genetics, was one of the witnesses asked to testify. Dr. David Carpenter, director of the Institute for Health and Environment at the University of Albany; Dr. Ronald Herberman, director of the University of Pittsburgh Cancer Institute; Mr. Julius Knapp, deputy chief of the Office of Engineering and Technology at the Federal Communications Commission; and Mrs. Ellie Marks, an advocate from California, also participated as panel witnesses. Dr. Hoover's statement for the record will be available on the NCI Office of Government and Congressional Relations Web site at http://legislative.cancer.gov/.

The NCI Cancer Bulletin featured an article about cell phones and brain cancer in the September 23 issue. 

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov